Literature DB >> 2681518

Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.

A Walz1, B Dewald, V von Tscharner, M Baggiolini.   

Abstract

Platelet basic protein (PBP), connective tissue-activating peptide III (CTAP-III), and platelet factor 4 (PF-4) were purified from human platelet release supernatants by heparin-Sepharose ion-exchange and reversed-phase HPLC, and their neutrophil-activating effects were compared with those of NAP-2, a peptide of 70 amino acids corresponding to part of the sequence of PBP (1) and with sequence homology to NAF/NAP-1. NAP-2-induced elastase release and a rise in cytosolic free Ca2+ at concentrations between 0.3 and 100 nM, and neutrophil chemotaxis at concentrations between 0.03 and 10 nM. It was half as potent as NAF/NAP-1 in inducing exocytosis but showed the same activity in the other responses. By contrast, only minimal if any effects were obtained with PBP, CTAP-III, and PF-4 up to 100 nM. NAP-2 thus appears to behave like a typical chemotactic receptor agonist. It could be generated from PBP and/or CTAP-III released from activated platelets and lead to the accumulation of neutrophils in platelet aggregates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681518      PMCID: PMC2189513          DOI: 10.1084/jem.170.5.1745

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Novel neutrophil-stimulating peptides.

Authors:  J Westwick; S W Li; R D Camp
Journal:  Immunol Today       Date:  1989-05

2.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  In vitro effects of platelet factor 4 on normal human neutrophil functions.

Authors:  S T Bebawy; J Gorka; T M Hyers; R O Webster
Journal:  J Leukoc Biol       Date:  1986-04       Impact factor: 4.962

4.  Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin.

Authors:  J C Holt; M E Harris; A M Holt; E Lange; A Henschen; S Niewiarowski
Journal:  Biochemistry       Date:  1986-04-22       Impact factor: 3.162

5.  Platelet factor 4 is chemotactic for neutrophils and monocytes.

Authors:  T F Deuel; R M Senior; D Chang; G L Griffin; R L Heinrikson; E T Kaiser
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Platelets, fibroblasts, and inflammation: tissue reactions to platelets injected subcutaneously.

Authors:  P W Braunstein; H F Cuénoud; I Joris; G Majno
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

7.  Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.

Authors:  C W Castor; J W Miller; D A Walz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator.

Authors:  C W Castor; J C Ritchie; C H Williams; M E Scott; S L Whitney; S L Myers; T B Sloan; B E Anderson
Journal:  Arthritis Rheum       Date:  1979-03

9.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

10.  Chemotactic activity of platelet alpha granule proteins for fibroblasts.

Authors:  R M Senior; G L Griffin; J S Huang; D A Walz; T F Deuel
Journal:  J Cell Biol       Date:  1983-02       Impact factor: 10.539

View more
  47 in total

Review 1.  Chemokines--linking receptors to response.

Authors:  Malcolm L Watson
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.

Authors:  S A Jones; M Wolf; S Qin; C R Mackay; M Baggiolini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

4.  Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.

Authors:  B D Car; M Baggiolini; A Walz
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

5.  Monocyte-derived CXCL7 peptides in the marrow microenvironment.

Authors:  Manoj M Pillai; Mineo Iwata; Norihiro Awaya; Lynn Graf; Beverly Torok-Storb
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

6.  A recipe for designing water-soluble, beta-sheet-forming peptides.

Authors:  K H Mayo; E Ilyina; H Park
Journal:  Protein Sci       Date:  1996-07       Impact factor: 6.725

Review 7.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 8.  Emerging roles for platelets as immune and inflammatory cells.

Authors:  Craig N Morrell; Angela A Aggrey; Lesley M Chapman; Kristina L Modjeski
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

9.  Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.

Authors:  Khalil Bdeir; Kandace Gollomp; Marta Stasiak; Junjie Mei; Izabela Papiewska-Pajak; Guohua Zhao; G Scott Worthen; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

10.  Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2, CR3) acts as a functional receptor for platelet factor 4.

Authors:  Valeryi K Lishko; Valentin P Yakubenko; Tatiana P Ugarova; Nataly P Podolnikova
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.